Neuroscience

EEG-Based ML Predicts Anxiety in Adolescents with MDD

A new study leverages EEG and machine learning to predict anxiety in adolescents with major depressive disorder, enhancing personalized diagnostics.

Published July 14, 2026 Read 2 min 379 words By The Psychedelic Journal

EEG and Machine Learning: A New Diagnostic Tool

A recent study has developed an EEG-based machine learning framework to predict comorbid anxiety in adolescents with major depressive disorder (MDD). This innovative approach uses electroencephalography (EEG) biomarkers to identify anxiety symptoms, providing a transparent, data-driven tool for personalized diagnostics in youth mental health. The study involved 200 adolescents aged 12-18, all drug-free for at least two weeks, and utilized various EEG features to train machine learning models.

Mechanism and Key Findings

The study extracted 32 EEG features, including time-domain, frequency-domain, nonlinear, Hjorth, and entropy-based metrics. Seven machine learning models were trained and validated using a 3-fold nested cross-validation approach. The Light Gradient Boosting Machine (LightGBM) demonstrated superior predictive performance, achieving an area under the curve (AUC) value of 0.72 ± 0.05, accuracy of 0.83 ± 0.02, and a precision of 0.91 ± 0.02. SHAP (SHapley Additive exPlanations) analysis identified key EEG features such as the normalized first difference, the ratio of Alpha to Beta, and Theta-band power as significant predictors of anxiety.

Implications for Mental Health Diagnostics

This framework aligns with translational psychiatry goals by advancing biomarker-based diagnostics in youth mental health. While not directly linked to psychedelic therapies, the insights gained from this study could inform future treatment approaches, including the potential integration of psychedelics in managing comorbid anxiety in adolescents with MDD. The ability to predict anxiety with high precision can enhance early intervention strategies and personalize treatment plans.

Risks and Unknowns

Despite the promising results, several risks and unknowns remain. The study's reliance on a specific age group and drug-free status limits its generalizability. Additionally, the predictive model's performance, while robust, still leaves room for improvement in real-world settings. Further research is needed to validate these findings across diverse populations and to explore the integration of such diagnostic tools with existing treatment modalities.

Future Directions in Youth Mental Health

Looking forward, the integration of EEG-based machine learning frameworks in clinical practice could revolutionize the early detection and treatment of comorbid anxiety in adolescents with MDD. Continued advancements in this area may lead to more effective, personalized treatment plans, potentially incorporating novel therapies such as psychedelics. As research progresses, it will be crucial to address existing limitations and expand the applicability of these diagnostic tools to broader populations.

Primary source: https://openalex.org/W7168328084 — referenced for fact-checking; this analysis is independent commentary by the The Psychedelic Journal editorial team.
Found this useful?

Get tomorrow's briefing in your inbox

Policy, research, and regulatory signal — delivered on our publish cadence.

Free. No spam. Unsubscribe anytime.